The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2022
Filed:
Feb. 13, 2020
Applicant:
Prilenia Neurotherapeutics Ltd., Herzliya, IL;
Inventors:
Michal Geva, Even-Yehuda, IL;
Ralph Laufer, Tel Aviv, IL;
Michael Hayden, Herzliya, IL;
Neta Zach, Tel Aviv, IL;
Assignee:
Prilenia Neurotherapeutics Ltd., Herzliya, IL;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61P 25/14 (2006.01); A61K 9/00 (2006.01); A61K 31/185 (2006.01); A61K 31/222 (2006.01); A61K 31/4152 (2006.01); A61K 31/426 (2006.01); A61K 31/4748 (2006.01); A61K 31/49 (2006.01);
U.S. Cl.
CPC ...
A61K 31/44 (2013.01); A61K 9/0053 (2013.01); A61K 31/185 (2013.01); A61K 31/222 (2013.01); A61K 31/4152 (2013.01); A61K 31/426 (2013.01); A61K 31/4748 (2013.01); A61K 31/49 (2013.01); A61P 25/14 (2018.01);
Abstract
Provided herein is a method for treating a human subject afflicted with ALS by administering to the subject a therapeutically effective amount of pridopidine as monotherapy or together with riluzole, edaravone, combination of dextromethorphan/quinidine, sodium phenylbutyrate (PB), tauroursodeoxycholic acid or combination of sodium phenylbutyrate (PB)/tauroursodeoxycholic acid (i.e. AMX0035) as combination or add-on therapy.